Fri-06-06-2014, 13:36 PM
Strides Arcolab an Indian pharmaceutical company headquartered at Bangalore in southern India has been given FDA approval for Methoxsalen
Source: NO LINKS ALLOWED
Quote:
Strides Arcolab today announced that it has received approval from the United States Food & Drug Administration (USFDA) for Methoxsalen Capsules USP, 10 mg (Soft Gelatin Capsules).
According to IMS data, the US market for generic Methoxsalen Capsule is approximately USD 13.6 Million, with no generic player.
The product will be manufactured at the Company’s USFDA approved Oral dosage facility at Bangalore and marketed directly by Strides in the US Market.
About Methoxsalen Capsules:
Methoxsalen is a drug used to treat psoriasis, eczema, vitiligo and some cutaneous lymphomas in conjunction with exposing the skin to UVA light from lamps or sunlight.
Methoxsalen modifies the way skin cells receive the UVA radiation, clearing up the disease.
Source: NO LINKS ALLOWED